| Literature DB >> 28096284 |
Marios Panagiotou1, Alistair C Church1, Martin K Johnson1, Andrew J Peacock1.
Abstract
Pulmonary vascular and cardiac impairment is increasingly appreciated as a major adverse factor in the natural history of interstitial lung disease. This clinically orientated review focuses on the current concepts in the pathogenesis, pathophysiology and implications of the detrimental sequence of increased pulmonary vascular resistance, pre-capillary pulmonary hypertension and right heart failure in interstitial lung disease, and provides guidance on its management.Entities:
Mesh:
Year: 2017 PMID: 28096284 DOI: 10.1183/16000617.0053-2016
Source DB: PubMed Journal: Eur Respir Rev ISSN: 0905-9180